VAT Group AG (LON:0RFL)

Verve Therapeutics Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	148.24	158.12	144.11	174.37	127.15	137.87
Short-Term Investments	0.04	0.03	0.04	0.04	0.03	0.03
Cash & Short-Term Investments	148.28	158.15	144.15	174.4	127.19	137.9
Cash Growth	27.34%	9.72%	-17.35%	37.12%	-7.77%	25.53%
Accounts Receivable	158.33	131.52	98.61	151.67	116.12	89.97
Other Receivables	2.54	11.53	12.06	14.14	8.99	4.94
Receivables	160.87	143.05	110.67	165.81	125.11	94.91
Inventory	236.59	247.6	188.46	229.25	152.76	104.75
Prepaid Expenses	9.93	5.6	4.38	9.62	4.05	1.58
Other Current Assets	27.7	3	18.05	10.76	4.58	7.24
Total Current Assets	583.36	557.4	465.69	589.84	413.68	346.39
Property, Plant & Equipment	313.81	273.18	234.82	204.32	158.54	146.47
Long-Term Investments	5.97	3.94	0.89	0.88	0.86	0.85
Goodwill	-	183.92	183.92	183.92	183.92	183.72
Other Intangible Assets	441.23	233.57	252.32	266.56	278.21	302.06
Long-Term Deferred Tax Assets	10.49	9.22	4.98	6.36	5.35	5.98
Long-Term Deferred Charges	-	30.87	23.18	20.08	20.62	-
Other Long-Term Assets	2.58	2.65	2.65	2.83	3.69	3.6
Total Assets	1,357	1,295	1,168	1,275	1,065	989.06
Accounts Payable	86.51	72.44	50.51	83.99	50.31	32.42
Accrued Expenses	62.21	75.97	47.49	54.77	54.63	42.32
Current Portion of Long-Term Debt	202.98	2.44	2.07	199.85	-	58.42
Current Portion of Leases	-	-	-	3.15	2.11	3.1
Current Income Taxes Payable	36.86	31.13	20.61	47.7	30.15	22.79
Current Unearned Revenue	-	0.19	-	0.01	0.13	0.64
Other Current Liabilities	2.64	44.46	23.41	42.5	22.12	8.35
Total Current Liabilities	391.2	226.63	144.08	431.98	159.43	168.04
Long-Term Debt	207.14	226.9	196.91	0.08	199.72	199.93
Long-Term Leases	-	12.45	8.32	8.1	5.12	4.89
Long-Term Deferred Tax Liabilities	40.67	40.9	43.49	49.36	49.82	45.81
Other Long-Term Liabilities	2.89	2.18	1.55	2.21	2.62	0.26
Total Liabilities	663.12	540.87	411.3	494.47	430.5	444.48
Common Stock	3	3	3	3	3	3
Additional Paid-In Capital	0.34	0.34	0.34	0.34	6.48	73.97
Retained Earnings	703.43	776.77	768.18	781.07	624.79	461.42
Treasury Stock	-10.13	-9.86	-6.8	-5.32	-4.5	-0.41
Comprehensive Income & Other	-2.32	-16.38	-7.57	1.22	4.61	6.6
Shareholders' Equity	694.32	753.88	757.16	780.32	634.37	544.57
Total Liabilities & Equity	1,357	1,295	1,168	1,275	1,065	989.06
Total Debt	410.12	241.79	207.31	211.18	206.94	266.34
Net Cash (Debt)	-261.84	-83.63	-63.16	-36.78	-79.76	-128.44
Net Cash Per Share	-8.73	-2.79	-2.11	-1.23	-2.66	-4.28
Filing Date Shares Outstanding	29.99	29.98	29.98	29.98	29.99	29.99
Total Common Shares Outstanding	29.99	29.98	29.98	29.98	29.99	29.99
Working Capital	192.16	330.77	321.61	157.86	254.26	178.34
Book Value Per Share	23.15	25.15	25.26	26.03	21.16	18.16
Tangible Book Value	253.1	336.39	320.92	329.84	172.24	58.8
Tangible Book Value Per Share	8.44	11.22	10.70	11.00	5.74	1.96
Land	-	14.57	13.75	14.86	7.88	7.88
Buildings	-	144.58	96.43	96.76	95.86	95.73
Machinery	-	201.53	165.91	150.94	144.19	138.52
Construction In Progress	-	75.17	101.42	72.36	31.14	7.96
Order Backlog	-	370.3	291.6	517.7	461.2	145.3

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.